Thrivent Financial for Lutherans Sells 939,907 Shares of Corteva, Inc. $CTVA

Thrivent Financial for Lutherans reduced its position in Corteva, Inc. (NYSE:CTVA) by 91.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 84,644 shares of the company’s stock after selling 939,907 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Corteva were worth $5,724,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of CTVA. Norges Bank bought a new position in Corteva in the 2nd quarter valued at $434,220,000. Pacer Advisors Inc. boosted its stake in shares of Corteva by 4,007.1% during the third quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company’s stock valued at $165,164,000 after purchasing an additional 2,382,715 shares during the period. WCM Investment Management LLC grew its holdings in shares of Corteva by 29.6% in the second quarter. WCM Investment Management LLC now owns 9,044,706 shares of the company’s stock worth $672,836,000 after purchasing an additional 2,066,519 shares during the last quarter. Marshall Wace LLP grew its holdings in shares of Corteva by 1,365.9% in the second quarter. Marshall Wace LLP now owns 1,809,764 shares of the company’s stock worth $134,882,000 after purchasing an additional 1,686,309 shares during the last quarter. Finally, National Pension Service increased its stake in Corteva by 148.4% in the 2nd quarter. National Pension Service now owns 2,454,601 shares of the company’s stock worth $182,941,000 after buying an additional 1,466,268 shares during the period. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Trading Up 0.2%

Shares of NYSE:CTVA opened at $72.63 on Friday. The company has a market capitalization of $49.08 billion, a PE ratio of 45.97, a P/E/G ratio of 1.84 and a beta of 0.75. The company has a current ratio of 1.43, a quick ratio of 1.07 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $77.41. The business’s fifty day simple moving average is $68.82 and its 200-day simple moving average is $68.42.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. Corteva’s revenue was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is currently 45.57%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Wells Fargo & Company boosted their price objective on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a research report on Thursday. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 22nd. The Goldman Sachs Group reissued a “buy” rating and issued a $88.00 price objective on shares of Corteva in a research note on Thursday. Weiss Ratings restated a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. Finally, Wolfe Research upped their target price on Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $82.37.

Corteva News Roundup

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Several sell‑side firms lifted targets and kept bullish ratings, signaling analyst confidence in longer‑term upside: Deutsche Bank to $90 (buy), Wolfe Research to $86 (outperform), and RBC to $89 (outperform). Deutsche Bank raise Wolfe Research raise RBC raise
• Positive Sentiment: Brokerage consensus remains constructive (consensus “Moderate Buy”), which supports demand for the shares despite near‑term noise. Consensus Moderate Buy
• Positive Sentiment: Strategic commentary highlights Corteva’s expanding role in global agriculture and technology leadership—positive for medium‑term growth expectations. Corteva expands role
• Neutral Sentiment: Analyst views are mixed across publications — some highlight long‑term upside tied to licensing and settlements, while others argue valuation limits near‑term gains. Investors should weigh catalyst timing. Bull case analysis Conflicting analyst views
• Neutral Sentiment: Technical analysis pieces warn of a key structural test — useful for traders but not definitive for fundamentals; could increase short‑term volatility. Technical caution
• Negative Sentiment: Q4 results missed revenue expectations (seasonal timing and weaker crop‑protection/seed demand); revenue miss and a wider loss drove an after‑hours selloff. Those operational misses are the main near‑term headwind. Q4 revenue miss After‑hours fall
• Negative Sentiment: JPMorgan downgraded Corteva from overweight to neutral (citing valuation/limited near‑term upside), which can cool momentum among institutional buyers. JPMorgan downgrade
• Negative Sentiment: Market reaction to the earnings miss (seasonal timing) and mixed guidance elements increases short‑term uncertainty even as analysts argue for longer‑term upside — expect higher intraday volatility. Seasonal timing impact

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.